Priority Date: 26.02.10 (US 20100308520P)

PROTEIN C ZYMOGEN AND METHODS OF USE THEREOF TO PREVENT CANCER METASTASES

  • Application ID: EP11748220
  • Status: PATENT GRANTED

Attorney

operating since 1894
Headquarter in London and 5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 26.02.2010 - Priority Date (US 20100308520P)
  • 01.09.2011 - Publication A1 (WO2011106759)
  • 02.01.2013 - Publication A1 (EP2539448)
  • 14.12.2016 - Publication B1 (EP2539448)